Search

Your search keyword '"Bernard Nordlinger"' showing total 229 results

Search Constraints

Start Over You searched for: Author "Bernard Nordlinger" Remove constraint Author: "Bernard Nordlinger"
229 results on '"Bernard Nordlinger"'

Search Results

51. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983

52. Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?

53. Recommandations pour la prise en charge des tumeurs stromales gastro-intestinales

54. Docetaxel Plus Gemcitabine or Docetaxel Plus Cisplatin in Advanced Pancreatic Carcinoma: Randomized Phase II Study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group

55. Adjuvant and neoadjuvant treatment in resectable and non-resectable metastatic colon cancer

56. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial

57. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer

58. The role of irinotecan in the treatment of colorectal cancer metastases: surgeons and oncologists in partnership

59. Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases

61. Avancées récentes dans la prise en charge des métastases hépatiques des cancers colorectaux

62. Surgery of liver metastases from colorectal cancer: new promises

63. Colorectal metastasis (liver and lung)

64. Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)

65. Liver Metastases From Colorectal Cancer: The Turning Point

66. The EORTC Gastrointestinal Tract Cancer Group

67. Genomic profiling of ampullary adenocarcinoma (AA): Insights from a comparative analysis of pancreatic and intestinal adenocarcinoma and opportunities for targeted therapies use

68. Semiautomatic Macroencapsulation of Fresh or Cryopreserved Porcine Hepatocytes Maintain Their Ability for Treatment of Acute Liver Failure

69. The Eortc Gastrointestinal Group Trials

70. Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression

71. Survival and functions of encapsulated porcine hepatocytes after allotransplantation or xenotransplantation without immunosuppression

72. Le foie bioartificiel interne

73. Long-Term Prognostic Value of Positive Peritoneal Washing in Colon Cancer

74. LETHAL FECALOMA

76. Traitement curatif des cancers du rectum

77. Transplantation intrapéritonéale d'hépatocytes isolés de porc: le foie bioartificiel implantable

78. Long-term survival following resection of colorectal hepatic metastases

79. EVIDENCE FOR SURVIVAL AND METABOLIC ACTIVITY OF ENCAPSULATED XENOGENEIC HEPATOCYTES TRANSPLANTED WITHOUT IMMUNOSUPPRESSION IN GUNN RATS1

80. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer

81. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

82. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients

83. Immunosuppressive effects of endotoxins and bile acidsin vivoin the rat

84. Adénocarcinome ovarien, tumeur primitive ou métastase d’un adénocarcinome colique

85. Permeability and biocompatibility of a new hydrogel used for encapsulation of hepatocytes

86. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 andBM-40/SPARC genes

87. Transplantation of allogeneic hepatocytes without immunosuppression: Long-term survival

88. Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor

89. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

90. Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

91. Health care delivery system in France: Effects on surgical education

92. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases

93. Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate

95. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials

96. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome

97. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment

98. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

99. Colorectal cancer

100. Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery

Catalog

Books, media, physical & digital resources